Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome. (Q53409844)

14 May 2018

title

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome. (English)

1 reference

14 May 2018

1 reference

William David Foulkes

1

1 reference

14 May 2018

Steven A. Narod

10

object named as

S A Narod

1 reference

14 May 2018

author name string

P O Chappuis

2

1 reference

14 May 2018

N Wong

3

1 reference

14 May 2018

J S Brunet

4

1 reference

14 May 2018

D Vesprini

5

1 reference

14 May 2018

F Rozen

6

1 reference

14 May 2018

Z Q Yuan

7

1 reference

14 May 2018

M N Pollak

8

1 reference

14 May 2018

G Kuperstein

9

1 reference

14 May 2018

L R Bégin

11

1 reference

14 May 2018

publication date

1 March 2000

1 reference

14 May 2018

published in

Annals of Oncology

1 reference

14 May 2018

volume

11

1 reference

14 May 2018

issue

3

1 reference

14 May 2018

page(s)

307-313

1 reference

14 May 2018

Prognostic factors and treatment decisions in axillary-node-negative breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

The influence of familial and hereditary factors on the prognosis of breast cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

BRCA1 and BRCA2: from molecular genetics to clinical medicine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

BRCA-associated breast cancer in young women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Response to radiation therapy and prognosis in breast cancer patients with BRCA1 and BRCA2 mutations.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Germ-line BRCA1 mutations in women with sporadic breast cancer: clinical correlations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Survival After Breast Cancer in Ashkenazi Jewish BRCA1 and BRCA2 Mutation Carriers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

The functions of breast cancer susceptibility gene 1 (BRCA1) product and its associated proteins

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

p53 mutation with frequent novel condons but not a mutator phenotype in BRCA1- and BRCA2-associated breast tumours

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Frequency of p53 mutations in breast carcinomas from Ashkenazi Jewish carriers of BRCA1 mutations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

IARC Database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualisation tools

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

p53 protein accumulation and response to adjuvant chemotherapy in premenopausal women with node-negative early breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Accumulation of p53 Tumor Suppressor Gene Protein: An Independent Marker of Prognosis in Breast Cancers

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

p53 mutations in BRCA1-associated familial breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Functions of the BRCA1 and BRCA2 genes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008340723974

7 January 2021

Identifiers

DOI

10.1023/A:1008340723974

1 reference

14 May 2018

PubMed ID

10811497

1 reference

14 May 2018